相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Trypanosoma cruzi infection induces proliferation and impairs migration of a human breast cancer cell line
Anna Clara Azevedo Silveira et al.
EXPERIMENTAL PARASITOLOGY (2023)
Epitopes in the Glycosylphosphatidylinositol Attachment Signal Peptide of Trypanosoma cruzi Mucin Proteins Generate Robust but Delayed and Nonprotective CD8+T Cell Responses
Molly E. Bunkofske et al.
JOURNAL OF IMMUNOLOGY (2023)
Cdc42/Rac Interactive Binding Containing Effector Proteins in Unicellular Protozoans With Reference to Human Host: Locks of the Rho Signaling
Preeti Umarao et al.
FRONTIERS IN GENETICS (2022)
Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
Nora Berois et al.
CANCERS (2022)
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection
Alba Abras et al.
CLINICAL MICROBIOLOGY REVIEWS (2022)
New and Emerging Targeted Therapies for Advanced Breast Cancer
Kristie H. Lau et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Reshaping endoplasmic reticulum quality control through the unfolded protein response
R. Luke Wiseman et al.
MOLECULAR CELL (2022)
An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment
Javier Martin-Escolano et al.
ACS INFECTIOUS DISEASES (2022)
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment
Quan Gao et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
Ruoning Yang et al.
MOLECULAR BIOMEDICINE (2022)
Chagas Disease: Chronic Chagas Cardiomyopathy
Natalia Giraldo Echavarria et al.
CURRENT PROBLEMS IN CARDIOLOGY (2021)
Revisiting the role of CD4+T cells in cancer immunotherapy-new insights into old paradigms
Rong En Tay et al.
CANCER GENE THERAPY (2021)
Drug rechanneling: A novel paradigm for cancer treatment
Itishree Kaushik et al.
SEMINARS IN CANCER BIOLOGY (2021)
Topical review on nano-vaccinology: Biochemical promises and key challenges
Tean Zaheer et al.
PROCESS BIOCHEMISTRY (2021)
Role of formyl peptide receptor 2 (FPR2) in modulating immune response and heart inflammation in an experimental model of acute and chronic Chagas disease
Rafaela das Dores Pereira et al.
CELLULAR IMMUNOLOGY (2021)
Calreticulin-Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients
Michal Kielbik et al.
CELLS (2021)
Cancer Vaccines: Antigen Selection Strategy
Yue Zhao et al.
VACCINES (2021)
Nanomedicine-Boosting Tumor Immunogenicity for Enhanced Immunotherapy
Jing Huang et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Proteomic changes in Trypanosoma cruzi epimastigotes treated with the proapoptotic compound PAC-1
Emanuella de Castro Andreassa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2021)
Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy
Faisal Raza et al.
ADVANCED HEALTHCARE MATERIALS (2021)
All Roads Lead to Cytosol: Trypanosoma cruzi Multi-Strategic Approach to Invasion
Gabriel Ferri et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
CD4+T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy
Jennifer R. Richardson et al.
CANCERS (2021)
Expression Regulation and Function of T-Bet in NK Cells
Chen Huang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Latest Innovations and Nanotechnologies with Curcumin as a Nature-Inspired Photosensitizer Applied in the Photodynamic Therapy of Cancer
Laura Marinela Ailioaie et al.
PHARMACEUTICS (2021)
Chagas Cardiomyopathy: From Romana Sign to Heart Failure and Sudden Cardiac Death
Antonia Pino-Marin et al.
PATHOGENS (2021)
Sequentially pH-Responsive Drug-Delivery Nanosystem for Tumor Immunogenic Cell Death and Cooperating with Immune Checkpoint Blockade for Efficient Cancer Chemoimmunotherapy
Mingxia Jiang et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Recent Advances in Engineered Materials for Immunotherapy-Involved Combination Cancer Therapy
Jun-Long Liang et al.
ADVANCED MATERIALS (2021)
Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes
H. Kuroda et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
A natural product, Piperlongumine (PL), increases tumor cells sensitivity to NK cell killing
Lukman O. Afolabi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
Tripti Khare et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The current knowledge concerning solid cancer and therapy
Masoud Najafi et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)
Interleukin-17 family members in health and disease
Soo-Hyun Chung et al.
INTERNATIONAL IMMUNOLOGY (2021)
Therapeutic cancer vaccines
Mansi Saxena et al.
NATURE REVIEWS CANCER (2021)
Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism
Ilaria Elia et al.
NATURE METABOLISM (2021)
Epidemiology and pathogenesis of maternal-fetal transmission of Trypanosoma cruzi and a case for vaccine development against congenital Chagas disease
Lizette Rios et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Immune modulation by mesenchymal stem cells
Wei Jiang et al.
CELL PROLIFERATION (2020)
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
Jose Maria G. Ruiz de Morales et al.
AUTOIMMUNITY REVIEWS (2020)
Challenges in liver cancer and possible treatment approaches
David Anwanwan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies
Sara K. Daniel et al.
SEMINARS IN CANCER BIOLOGY (2020)
Resistance to Checkpoint Inhibition in Cancer Immunotherapy
Luisa Barrueto et al.
TRANSLATIONAL ONCOLOGY (2020)
Trypanosoma cruzi Calreticulin: Immune Evasion, Infectivity, and Tumorigenesis
Galia Ramirez-Toloza et al.
TRENDS IN PARASITOLOGY (2020)
Interleukin-17 mediated immunity during infections with Trypanosoma cruzi and other protozoans
Maria Carolina Amezcua Vesely et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control
Augusto E. Bivona et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations
Yuan Lin et al.
CANCER CELL INTERNATIONAL (2020)
Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
Filippo Galli et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infection
Martin C. Taylor et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Vital Signs: Colorectal Cancer Screening Test Use - United States, 2018
Djenaba A. Joseph et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Immunogenic cell death in colon cancer prevention and therapy
Hang Ruan et al.
MOLECULAR CARCINOGENESIS (2020)
The Recombinant Form ofTrypanosoma cruziP21 Controls Infection by Modulating Host Immune Response
Flavia Alves Martins et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence
Galia Ramirez-Toloza et al.
FRONTIERS IN IMMUNOLOGY (2020)
Engineered Nanoparticles for Cancer Vaccination and Immunotherapy
Marisa E. Aikins et al.
ACCOUNTS OF CHEMICAL RESEARCH (2020)
Natural killer cells in cancer biology and therapy
Song-Yang Wu et al.
MOLECULAR CANCER (2020)
In vitro Treatment of a Murine Mammary Adenocarcinoma Cell Line with Recombinant Trypanosoma cruzi Calreticulin Promotes Immunogenicity and Phagocytosis
Eduardo Sosoniuk-Roche et al.
MOLECULAR IMMUNOLOGY (2020)
Chemical Strategies to Boost Cancer Vaccines
Wen-Hao Li et al.
CHEMICAL REVIEWS (2020)
TLR4 agonist protects againstTrypanosoma cruziacute lethal infection by decreasing cardiac parasite burdens
Liliana E. Villanueva-Lizama et al.
PARASITE IMMUNOLOGY (2020)
Lipids in the tumor microenvironment: From cancer progression to treatment
Kevin C. Corn et al.
PROGRESS IN LIPID RESEARCH (2020)
Calreticulin exploits TGF-β for extracellular matrix induction engineering a tissue regenerative process
Unnati M. Pandya et al.
FASEB JOURNAL (2020)
The Glycan Structure of T. cruzi mucins Depends on the Host. Insights on the Chameleonic Galactose
Maria Eugenia Giorgi et al.
MOLECULES (2020)
The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration
Marco E. Bianchi et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Recombinant Protein Based on Trypanosoma cruzi P21 Interacts With CXCR4 Receptor and Abrogates the Invasive Phenotype of Human Breast Cancer Cells
Bruna Cristina Borges et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Roles of IFN-γ in tumor progression and regression: a review
Dragica Jorgovanovic et al.
BIOMARKER RESEARCH (2020)
The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
Yi Shi et al.
FRONTIERS IN PHARMACOLOGY (2020)
Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer
Louis Lantier et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Anti-inflammatory and immune-modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation
Seyed-Morteza Ehteshamfar et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer
Arianna Brevi et al.
FRONTIERS IN IMMUNOLOGY (2020)
CD4 T Helper Cell Subsets and Related Human Immunological Disorders
Xiaoliang Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
The cancer-natural killer cell immunity cycle
Nicholas D. Huntington et al.
NATURE REVIEWS CANCER (2020)
Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Xiaopin Duan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer
Maha M. Eissa et al.
INVESTIGATIONAL NEW DRUGS (2019)
Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis
Aldona Kasprzak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth et al.
NPJ VACCINES (2019)
Ovarian Cancer: An Integrated Review
Christine Stewart et al.
SEMINARS IN ONCOLOGY NURSING (2019)
Evolving Evidence of Calreticulin as a Pharmacological Target in Neurological Disorders
Vignesh Kotian et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes
Alejandro Schcolnik-Cabrera et al.
APOPTOSIS (2019)
Recent advances in carbohydrate-based cancer vaccines
Ke-Tao Jin et al.
BIOTECHNOLOGY LETTERS (2019)
Chagas disease as example of a reemerging parasite
Jeannette Guarner
SEMINARS IN DIAGNOSTIC PATHOLOGY (2019)
Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks
Andreia Peixoto et al.
FRONTIERS IN ONCOLOGY (2019)
Targeting metabolism to regulate immune responses in autoimmunity and cancer
Chirag H. Patel et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
IFN-γ: A cytokine at the right time, is in the right place
J. Daniel Burke et al.
SEMINARS IN IMMUNOLOGY (2019)
Chagas Disease: From Discovery to a Worldwide Health Problem
Karita Claudia Freitas Lidani et al.
FRONTIERS IN PUBLIC HEALTH (2019)
Employing Parasite Against Cancer: A Lesson From the Canine Tapeworm Echinococcus Granulocus
Wang Guan et al.
FRONTIERS IN PHARMACOLOGY (2019)
Experimental evidences that P21 protein controls Trypanosoma cruzi replication and modulates the pathogenesis of infection
Thaise L. Teixeira et al.
MICROBIAL PATHOGENESIS (2019)
Understanding CD8+ T Cell Immunity to Trypanosoma cruzi and How to Improve It
Eva V. Acosta Rodriguez et al.
TRENDS IN PARASITOLOGY (2019)
Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women
Yves Carlier et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
Global trends in colorectal cancer mortality: projections to the year 2035
Marzieh Araghi et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Professional and 'Amateur' Antigen-Presenting Cells In Type 2 Immunity
Martijn J. Schuijs et al.
TRENDS IN IMMUNOLOGY (2019)
NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives
Cristiana Lo Nigro et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)
Volker Schirrmacher
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Immunomodulatory Effects of Propolis and its Components on Basic Immune Cell Functions
K. Wolska et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Hepatic metastasis from colorectal cancer
Alfred Wei Chieh Kow
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Context-dependent roles of complement in cancer
Lubka T. Roumenina et al.
NATURE REVIEWS CANCER (2019)
Effect of Hydatid Cyst Fluid Antigens on Induction of Apoptosis on Breast Cancer Cells
Shima Daneshpour et al.
ADVANCED BIOMEDICAL RESEARCH (2019)
Emerging Roles of Calreticulin in Cancer: Implications for Therapy
Kavya Venkateswaran et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2018)
Amastigote Synapse: The Tricks of Trypanosoma cruzi Extracellular Amastigotes
Alexis Bonfim-Melo et al.
FRONTIERS IN MICROBIOLOGY (2018)
Heat Shock Proteins as Immunomodulants
Tawanda Zininga et al.
MOLECULES (2018)
Limited Foxp3+ Regulatory T Cells Response During Acute Trypanosoma cruzi Infection Is Required to Allow the Emergence of Robust Parasite-Specific CD8+ T Cell Immunity
Cintia L. Araujo Furlan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
Mechanistic Insights into the Anti-angiogenic Activity of Trypanosoma cruzi Protein 21 and its Potential Impact on the Onset of Chagasic Cardiomyopathy
Samuel Cota Teixeira et al.
SCIENTIFIC REPORTS (2017)
Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin
Galia Ramirez-Toloza et al.
FRONTIERS IN MICROBIOLOGY (2017)
Immune complexes in chronic Chagas disease patients are formed by exovesicles from Trypanosoma cruzi carrying the conserved MASP N-terminal region
Isabel Maria Diaz Lozano et al.
SCIENTIFIC REPORTS (2017)
Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers
Luis Ubillos et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Does native Trypanosoma cruzi calreticulin mediate growth inhibition of a mammary tumor during infection?
Paula Abello-Caceres et al.
BMC CANCER (2016)
Trypanosoma cruzi Invasion into Host Cells: A Complex Molecular Targets Interplay
Vanessa Leiria Campo et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Mechanisms of Infectivity and Evasion Derived from Microvesicles Cargo Produced by Trypanosoma cruzi
Bruna C. Borges et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Evasion of the Immune Response by Trypanosoma cruzi during Acute Infection
Mariana S. Cardoso et al.
FRONTIERS IN IMMUNOLOGY (2016)
Is the Antitumor Property of Trypanosoma cruzi Infetion Mediated by Its Calreticulin?
Galia Ramirez-Toloza et al.
FRONTIERS IN IMMUNOLOGY (2016)
Two endoplasmic reticulum proteins (calnexin and calreticulin) are involved in innate immunity in Chinese mitten crab (Eriocheir sinensis)
Ying Huang et al.
SCIENTIFIC REPORTS (2016)
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
Karine A. Cohen-Solal et al.
MOLECULAR CANCER (2015)
NK cells regulating T cell responses: mechanisms and outcome
Josh Crouse et al.
TRENDS IN IMMUNOLOGY (2015)
Translational challenges of animal models in Chagas disease drug development: a review
Eric Chatelain et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy
Thaise Lara Teixeira et al.
SCIENTIFIC REPORTS (2015)
A Human Type 5 Adenovirus-Based Trypanosoma cruzi Therapeutic Vaccine Reprograms Immune Response and Reverses Chronic Cardiomyopathy
Isabela Resende Pereira et al.
PLOS PATHOGENS (2015)
Is it all that bad when living with an intracellular protozoan?The role of Trypanosoma cruzi calreticulin in angiogenesis and tumor growth
Galia Ramirez-Toloza et al.
FRONTIERS IN ONCOLOGY (2015)
Antibodies against Mucin-Based Glycopeptides Affect Trypanosoma cruzi Cell Invasion and Tumor Cell Viability
Vanessa L. Campo et al.
CHEMBIOCHEM (2014)
Human Survivin and Trypanosoma cruzi Calreticulin Act in Synergy against a Murine Melanoma In Vivo
Lorena Aguilar-Guzman et al.
PLOS ONE (2014)
MUC1: a multifaceted oncoprotein with a key role in cancer progression
Sritama Nath et al.
TRENDS IN MOLECULAR MEDICINE (2014)
α-Selective glycosylation affords mucin-related GalNAc amino acids and diketopiperazines active on Trypanosoma cruzi
Maristela B. Martins-Teixeira et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Avirulent Toxoplasma gondii Generates Therapeutic Antitumor Immunity by Reversing Immunosuppression in the Ovarian Cancer Microenvironment
Jason R. Baird et al.
CANCER RESEARCH (2013)
Antitumor Activity of Human Hydatid Cyst Fluid in a Murine Model of Colon Cancer
Edgardo Berriel et al.
SCIENTIFIC WORLD JOURNAL (2013)
Parasites and cancers: parasite antigens as possible targets for cancer immunotherapy
Hossein Yousofi Darani et al.
FUTURE ONCOLOGY (2012)
Calreticulin signaling in health and disease
Wen-An Wang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Therapeutic live vaccines as a potential anticancer strategy
Azam Bolhassani et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Roles of Trypanosoma cruzi calreticulin in parasite-host interactions and in tumor growth
Galia Ramirez et al.
MOLECULAR IMMUNOLOGY (2012)
Functional cooperation between BiP and calreticulin in the folding maturation of a glycoprotein in Trypanosoma cruzi
Carlos A. Labriola et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2011)
Antitumor Effect of Malaria Parasite Infection in a Murine Lewis Lung Cancer Model through Induction of Innate and Adaptive Immunity
Lili Chen et al.
PLOS ONE (2011)
Trypanosoma cruzi as an effective cancer antigen delivery vector
Caroline Junqueira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Extracellular Trypanosoma cruzi calreticulin in the host-parasite interplay
Galia Ramirez et al.
TRENDS IN PARASITOLOGY (2011)
The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease
Caroline Junqueira et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2010)
Endoplasmic Reticulum Calcium Regulates the Retrotranslocation of Trypanosoma Cruzi Calreticulin to the Cytosol
Carlos A. Labriola et al.
PLOS ONE (2010)
Antiangiogenic and Antitumor Effects of Trypanosoma cruzi Calreticulin
Nandy C. Lopez et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Different cell death pathways induced by drugs in Trypanosoma cruzi: An ultrastructural study
Rubem F. S. Menna-Barreto et al.
MICRON (2009)
Anti-calreticulin immunoglobulin A (IgA) antibodies in refractory coeliac disease
D. Sanchez et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Tumour immunity: effector response to tumour and role of the microenvironment
Alberto Mantovani et al.
LANCET (2008)
A recombinant protein based on Trypanosoma cruzi surface molecule gp82 induces apoptotic cell death in melanoma cells
Vanessa D. Atayde et al.
MELANOMA RESEARCH (2008)
Expression of cancer-associated simple mucin-type O-glycosylated antigens in parasites
Eduardo Osinaga
IUBMB LIFE (2007)
The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi
V Ferreira et al.
JOURNAL OF IMMUNOLOGY (2004)